DOI: 10.1055/s-00023610

Drug Research

References

Raison CL. et al.
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

JAMA Psychiatry 2013;
70: 31-41

Download Bibliographical Data

Access:
Access: